Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysis.

Abstract

BACKGROUND:

The five-year cumulative incidence rate in patients diagnosed with stage I small-cell lung cancer (SCLC) who were instructed to undergo surgery was from 40 to 60%.The death competition influence the accuracy of the classical survival analyses. The aim of the study is to investigate the mortality of stage I small-cell lung cancer (SCLC) patients in the presence of competing risks according to a proportional hazards model, and to establish a competing risk nomogram to predict probabilities of both cause-specific death and death resulting from other causes.

METHODS:

The study subjects were patients diagnosed with stage I SCLC according to ICD-O-3. First, the cumulative incidence functions (CIFs) of cause-specific death, as well as of death resulting from other causes, were calculated. Then, a proportional hazards model for the sub-distribution of competing risks and a monogram were constructed to evaluate the probability of mortality in stage I SCLC patients.

RESULTS:

1811 patients were included in this study. The five-year probabilities of death due to specific causes and other causes were 61.5 and 13.6%, respectively. Tumor size, extent of tumor, surgery, and radiotherapy were identified as the predictors of death resulting from specific causes in stage I SCLC. The results showed that surgery could effectively reduce the cancer-specific death, and the one-year cumulative incidence dropped from 34.5 to 11.2%. Like surgery, chemotherapy and radiotherapy improved the one-year survival rate.

CONCLUSIONS:

We constructed a predictive model for stage I SCLC using the data from the SEER database. The proportional sub-distribution models of competing risks revealed the predictors of death resulting from both specific causes and other causes. The competing risk nomogram that we built to predict the prognosis showed good reliability and could provide beneficial and individualized predictive information for stage I SCLC patients.

• Authors: Jianjie Li, Qiwen Zheng, Xinghui Zhao, Jun Zhao, Tongtong An, Meina Wu, Yuyan Wang, Minglei Zhuo, Jia Zhong, Xue Yang, Bo Jia, Hanxiao Chen, Zhi Dong, Jingjing Wang, Yujia Chi, Xiaoyu Zhai, Ziping Wang
• Journal: BMC cancer (BMC Cancer) Vol. 20 Issue 1 Pg. 793 (Aug 24 2020) ISSN: 1471-2407 [Electronic] England
• PMID: 32838776 (Publication Type: Evaluation Study, Journal Article)

Topics

• Aged
• Cause of Death
• Female
• Follow-Up Studies
• Humans
• Lung Neoplasms (diagnosis, mortality, therapy)
• Male
• Middle Aged
• Neoplasm Staging
• Nomograms
• Pneumonectomy
• Prognosis
• Proportional Hazards Models
• Reproducibility of Results
• Risk Assessment (methods, statistics & numerical data)
• SEER Program (statistics & numerical data)
• Small Cell Lung Carcinoma (diagnosis, mortality, therapy)
• Survival Rate
• Treatment Outcome